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ABSTRACT 
 
DNA in the eukaryotic nucleus is organized into histone-DNA complex, so-called chromatin, 
through forming an array of nucleosomes. Each nucleosome consists of a 147bp DNA wrapped 
around a histone octamer harboring two of each H2A-H2B and H3-H4. Chromatin is orderly 
packed several times forming a chromosome structure. Active euchromatin and repressive 
heterochromatin are defined according to the degree of DNA compaction, of which 
euchromatin is open, and heterochromatin is condensed. Chromatin organization and its 
regulation always affect downstream gene transcriptions through different mechanisms, which 
consequently play crucial roles in many cellular and biological processes.   
 
In this thesis, we explored mechanisms of chromatin organization and its associated regulatory 
factors by using Schizosaccharomyces pombe. We identified an uncovered role of Abo1 in 
different heterochromatin locus. We demonstrated that Abo1 is involved in Clr4 mediated 
heterochromatin assembly through regulating H3K9me2 to H3K9me3 transition, related to 
distinct silencing machinery.  
 
 We also performed multiple in vitro experiments to investigate the functional role of the 
chromatin remodeler Hrp3, which is the orthologue of human CHD1. We generated several 
mutant strains where the non-catalytic domains were individually deleted. Our result suggested 
non-catalytic domains could further affect ATP hydrolyzing activity, and may further affect 
the chromatin remodeling function.  
 
In this thesis, we also investigated the outcomes of epigenetic and transcriptional regulation in 
hematopoietic development. We performed analysis on CAGE libraries in various primary cell 
types from the Fantom 5 project to study the usage of alternative transcriptional start site (TSS). 
Through mapping the TSS to Refseq, we identified alternative TSS that can lead protein 
domain loss. The alternative TSSs were shown to be expressed at different levels in different 
cell types or developmental stages, particularly in blood cells. We further investigated the 
functional consequence of alternative TSSs usage for KDM2B in Jurkat T-cells.   
 
To identify critical novel epigenetic regulators for myeloid differentiation, we performed a 
CRISPR-cas9 screen. We identified the chromatin remodeler CHD2 as a crucial regulator for 
megakaryocyte differentiation in the PMA inducible K-562 cell model. 
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1. Introduction  
1.1 Chromatin organization 
Eukaryotic genomes consist of chromosomes, each of which is packaged from a 
single linear DNA. Although the genome sizes are diverse, the basic chromosome 
structure is the same in all eukaryotic spices (Alberts, Johnson et al. 2002). A double-
stranded helical DNA, tightly wrapped around a histone octamer composed of H2A-
H2B dimers and H3-H4 tetramer constitute the nucleosome. Each nucleosome consists 
of a 147bp DNA formed nucleosome core particle (NCP), with additional a linker DNA 
and a histone protein H1 (Cooper 2000). This DNA-histone proteins interacted complex 
is called chromatin. To be compressed into a nucleus, chromatin is hierarchically 
packed into 30-nm fiber and 300-nm fiber, which is finally folded into a chromosome 
(Figure 1) (Alberts, Johnson et al. 2002, Annunziato 2008). The packaging of chromatin 
is regulated mainly through biochemically modified histones and remodeling enzymes, 
which cause remodeled chromatin structures and consequently affect downstream 
transcription of genes (Hubner, Eckersley-Maslin et al. 2013). 
 
 
 
Figure 1. View of chromatin organization and orderly compaction. Linear DNA is compacted into a 
chromosome hierarchically form string containing 11-nm nucleosomes. The nucleosome string then coils 
into 30-nm fiber that forms loops around 300-nm. The 300-nm fiber subsequently is folded to produce 
250nm-fiber, which finalize to coil into a chromosome. © 2013 Nature Education. All rights reserved. 
Figure reprinted with the permission from publisher. 
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1.1.1 Chromatin types 
In 1928, Heitz distinguished two types of chromatin according to the cytological 
difference detected through staining the nucleus of moss with nuclei dye. The chromatin 
regions with light staining were defined as euchromatin, while the regions with intense 
staining were defined as heterochromatin (Heitz 1928). Later, studies identified that the 
different intensity of staining in the two chromatin regions comes from the distinct 
compacted DNA density (Babu and Verma 1987). Nowadays, we know that 
euchromatin is featured by its less packed open structure and enrichment of genes. 
Transcription in euchromatin is usually active. On the contrary, heterochromatin is 
featured by its tightly packed structure with condensed DNA. Transcription in 
heterochromatin is usually repressed, but not always. Within the eukaryotic nucleus, 
cytogenetic studies also revealed that euchromatin is found in the inner body, while 
heterochromatin is more located in the inner face of the periphery (Oberdoerffer and 
Sinclair 2007, Kalverda, Röling et al. 2008). 
 
    Besides these two main classified categories, there are also multiple chromatin 
types reported. For instance, a study in Drosophila melanogaster revealed five principal 
chromatin types, which provided a global view and potential possibility of chromatin 
diversity in metazoan cells (Filion, van Bemmel et al. 2010).     
 
 
1.1.1.1 Euchromatin 
Most actively transcribed genes are located in the euchromatin, such as the 
housekeeping genes. The unfolded structure of euchromatin relies on the high level of 
histone acetylation and the absence of linker histone H1. Methylation on H3K4 and 
H3K79 are also present in euchromatin. Keeping the chromatin structure open allows 
for the recruitment of transcriptional regulatory proteins and RNA polymerase, and 
consequently initiate the transcription of genes (Hubner, Eckersley-Maslin et al. 2013).     
 
 
1.1.1.2 Heterochromatin 
Heterochromatin is a key chromatin feature of the eukaryotic genome. One crucial 
role of heterochromatin is to maintain the stability of the chromosome. It virtually 
participates in many cellular processes, from gene regulation to chromosome 
replication. The coverage of the genome for heterochromatin is quite diverse through 
eukaryotic organisms. Typical heterochromatin domains situate in particular positions 
on a chromosome, such as in the middle (centromere), at the ends 
(subtelomere/telomere) (Allshire and Madhani 2018, Janssen, Colmenares et al. 2018). 
In the 1960s, researchers performed a kinetic analysis of DNA renaturation and 
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characterized that heterochromatin contains more highly repeated DNA sequences 
compared to euchromatin (Britten and Kohne 1968, Vanrobays, Thomas et al. 2018). 
These highly repetitive sequences are required for the genome integrity during 
replication, such as repeats in centromere and telomere (discussed later). Besides the 
repetitive sequences, heterochromatin regions also comprise repressive genes that can 
only be transcribed in certain conditions/processes, such as cell cycling, environmental 
stress response, and development. Therefore, depending on the formation and strength 
of silencing, heterochromatin can be classically subdivided into constitutive and 
facultative heterochromatin (Brown 1966, Vanrobays, Thomas et al. 2018). 
Additionally, researchers reported a distinct repressive chromatin type (so-called black 
chromatin in the article) that is prevalent in Drosophila’s genome (~50%) (Filion, van 
Bemmel et al. 2010). 
 
Constitutive heterochromatin is always associated with permanent silent regions 
throughout the cell cycle. It is mostly composed of tandem repeats (so-called satellite 
repeats), but poor of genes. In most eukaryotic organisms, bulk constitutive 
heterochromatin situates at the pericentromeric region of centromere and at telomere 
on a chromosome (Saksouk, Simboeck et al. 2015). In humans, it is significantly more 
found on chromosome 1, 9, 16 19, and chromosome Y (Strachan and Read 2003). 
 
The centromere is a conserved structure on a eukaryotic chromosome where the 
kinetochore is constituted during mitotic segregation. It is essential for equal 
distribution of genetic information from mother to daughter cell during mitosis. Typical 
centromere chromatin contains two sub-domains: a centromere core flanked by 
pericentromeric regions. The nucleosomes in centromere core are specialized by the 
composition of H3-variant CENP-A, which is essential for kinetochore assembly. The 
length of centromere core varies in spices, from around 120bp occupying single 
nucleosome in budding yeast Saccharomyces cerevisiae to megabases-long satellite 
repeats array occupying hundreds of nucleosomes in humans (Black, Jansen et al. 2007, 
Aldrup-Macdonald and Sullivan 2014). Pericentromeric region also comprises non-
conserved repetitive sequences, from dg-dh in Schizosaccharomyces pombe to higher 
ordered tandem repeats (HOR) in human. Heterochromatin formation in the 
pericentromeric region depends on hypoacetylation and methylation of H3 lysine 9 and 
associated heterochromatin protein 1 (HP1). This heterochromatin structure is also 
essential for pericentromeric recruitment and stabilization of cohesin to construct sister 
chromatid cohesion (Nakayama, Rice et al. 2001, Nonaka, Kitajima et al. 2002, Volpe, 
Kidner et al. 2002, Smurova and De Wulf 2018). The silencing of the pericentromeric 
region, which is well established in S.pombe, provides a typical model of RNA 
interference (RNAi) silencing machinery in constitutive heterochromatin regions 
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(Volpe, Kidner et al. 2002). Repetitive sequences, dg-dh repeats (Outer repeats/otr) in 
S.pombe, is transcribed as long non-coding RNA and turned into dsRNA molecules by 
RNA-directed RNA polymerase complex (RDRC). This RDRC contains an RNA-
mediated RNA polymerase Rdp1, a helicase Hrr1, and a poly (A) RNA polymerase 
Cid12 (Motamedi, Verdel et al. 2004). The Dicer enzyme then cleaves the dsRNA into 
siRNA, which is captured by Ago1, the orthologue of the human PIWI family, and 
consequently constitutes transcriptional gene silencing (RITS) complex together with 
chromodomain containing protein 1 (Chp1) and Tas3 (Verdel, Jia et al. 2004). siRNA 
induced RITS complex helps to recruit and promote the RDRC complex to further 
establish a siRNA circular enhance system (Motamedi, Verdel et al. 2004, Sugiyama, 
Cam et al. 2005). Meanwhile, siRNA induced RITS is also associated with gathering 
and activating cryptic loci regulator complex (CLRC). Clr4 in CLRC, the orthologue 
of human methyltransferase SUV39H, can methylate lysine 9 of H3 and consequently 
engage the binding of the HP1 orthologue Swi6 and the Snf2/Hdac repressive complex 
(SHREC), which finally result in the establishment and spreading of repressive 
heterochromatin (Volpe, Kidner et al. 2002, Locke and Martienssen 2009). The SHREC 
complex, which consists of histone deacetylases Clr1, Clr2, Clr3, and chromatin 
remodeler Mit1, can accumulate to most types of heterochromatin region via Swi6 to 
generate transcriptional gene silencing (TGS) (Figure2) (Job, Brugger et al. 2016). 
 
 
 
Figure 2. RNAi silencing machinery in S.pombe. Long non-coding RNA is transcribed to produce 
siRNA via the function of the RDRC complex with components, as illustrated. siRNA interacted Ago1 
induces the recruitment of the RITS complex, which goes back to help to produce the second strand of 
lncRNA. Meanwhile, the activated RITS complex recruit CLRC to methylated H3K9. The binding of 
associated factors, such as Swi6, SHREC finalizes the chromatin compaction and transcriptional 
silencing (Biscotti, Canapa et al. 2015). Reprinted by permission from Springer Nature Customer Service 
Centre GmbH. 
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In mammalian cells, the silencing of the pericentromeric region relies on ncRNA 
(eg. HOR sequences) induced enrichment of H3K9me3 and the recruitment of HP1. 
Additional histone mark H4K20me3 also present via SUV4-20H. However, in Suv39h 
knockout mice, the H3K9me3 mark is abolished in the pericentromeric region. Instead, 
the Polycomb Repressive Complex 2 (PRC2) for H3K27me3 and the BEND3-NuRD 
complex-mediated pathway facilitate forming the heterochromatin (Saksouk, Simboeck 
et al. 2015, Nishibuchi and Déjardin 2017).  
 
The telomere is a heterochromatin region located at the end of the eukaryotic 
chromosome. It is composed of G-rich DNA repetitive sequences and binding of 
specific proteins. In mammalian cells, this tandem array is formed by numbers of 
TTAGGG repeats (O'Sullivan and Karlseder 2010). In eukaryotic cells, the telomere is 
shortened by the “end replication problem” in each cell division process, which leads 
to the 3’ end single-strand overhang and triggers the DNA damage response (Wynford-
Thomas and Kipling 1997). Therefore, the main function of the telomere complex is to 
prevent the loss of genetic information and chromosome fusion during replication. The 
enzyme telomerase helps to elongate the telomeric region to heal the shortening. It is 
not usually active in somatic cells, but active in germs cells, stem cells, and many cancer 
cells (Collins and Mitchell 2002). The telomere binding proteins (also called “shelterin”) 
in human is similar to S.pombe Among them, telomere binding protein Rap1 is recruited 
to the telomeric region through double-stranded telomeric repeats binding protein Taz1 
in S.pombe or TRF1/2 in human to inhibit the double-stranded DNA repairing pathway. 
Pot1 binds the single-strand end and links to the double-stranded region through the 
bridge of Ccq1- Tpz1-Poz1 in S.pombe and TPP1-TIN2 in human (Kanoh and Ishikawa 
2001, Diotti and Loayza 2011, Audry and Runge 2019). In S.pombe, the establishment 
of heterochromatin proteins and H3K9 methylation enrichment in telomeric ends is 
dependent on Taz1 (Kanoh, Sadaie et al. 2005, Deng, Norseen et al. 2009, Bandaria, 
Qin et al. 2016).  
 
Taz1, coupled with Ccq1, helps to recruit Clr3 of SHREC complex in the 
telomeric region. However, Clr3 enrichment is still retained in deletions of Taz1 and 
Ccq1. It is eliminated in the deletions of Chp1 and Taz1, suggesting an indirect role of 
RNAi machinery in the silencing of the telomere (Sugiyama, Cam et al. 2007). 
Epigenetic histone marks are diverse in human telomeric region because of the various 
subtypes in different cell types. In many human cell lines, the staining of H3K9me3 and 
HP1 is lowly co-localized with the staining of TRF1 or TRF2, which is further 
confirmed by ChIP studies, revealing the less enriched heterochromatin mark 
H3K9me3 in the telomeric region (Cubiles, Barroso et al. 2018).  
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Another example of constitutive heterochromatin is located in subtelomeric 
heterochromatin, where dg-dh repeats are also present. The silencing at this cen-like 
loci is also associated with pericentromeric-like RNAi silencing machinery (Chikashige, 
Kinoshita et al. 1989, Kanoh, Sadaie et al. 2005).  
 
Facultative heterochromatin, as discussed above, is transcriptional silent 
regions containing genes that can still potentially be converted into euchromatin. In 
mammalian cells, facultative heterochromatin includes regions such as inactive X 
chromosome, autosomal imprinted genomic loci, long-range silencing, local gene 
silencing (Trojer and Reinberg 2007). The molecular features of these silent regions are 
modifications like DNA methylation, H3K9 methylation, H3K27 methylation, 
H2AK119 ubiquitination, and related chromatin factors of SUV39H1/2, HP1, 
Polycomb Repressive Complex 1 and 2 (PRC1 and PRC2) that we will discuss in a later 
section. Here we want to introduce the silencing machinery in the subtelomeric region 
and heterochromatin islands as examples, especially in S.pombe. 
 
Subtelomere situates on a chromosome adjacent to the telomere ends. The length 
of the subtelomere region varies in different organisms, which is around ~50kb in 
S.pombe and 100~300kb in human. The composition is also highly variable. In budding 
yeast, subtelomere encompasses of X and Y elements. In human, subtelomere is even 
more polymorphic for the mixing of multiple types of segments containing different 
ORFs. In S.pombe, subtelomeric heterochromatin features by the enrichment of H3K9 
methylation. It is located between constitutive telomere ends and highly condensed 
“knob”. In “knob” region, both repressive and active histone modification levels are 
shallow (compare to bulk heterochromatin and euchromatin) (Buchanan, Durand-
Dubief et al. 2009, Matsuda, Chikashige et al. 2015). Deletion of subtelomeric 
heterochromatin sequences causes silence inbreak from telomere end to knob region, 
but does not affect the process of mitosis or meiosis. It is suggested that subtelomeric 
heterochromatin functions as a “buffer area” to prevent heterochromatin spreading from 
the telomere (Tashiro, Nishihara et al. 2017). Both repressive genes and dg-dh repeats 
present in the subtelomeric heterochromatin region. Telomeric associated sequence 
(TAS) is also found in subtelomere within around 6kb to the telomere with a low 
nucleosome occupancy. The silencing here is controlled by telomeric Ccq1 (van Emden, 
Forn et al. 2019). Therefore the silencing in subtelomeric heterochromatin is based on 
several types of machinery. The silencing for the repressive genes in subtelomeric 
regions requires hypoacetylation via deacetylase, such as Clr3, Sir2. It is also essential 
for the recruitment of CLRC (especially Clr4) and related methylation on H3K9 in order 
to recruit Swi6. The assembly of Swi6 and methylated H3K9 steadies the gathering of 
Clr4, which builds the platform of the heterochromatin structure through interacting 
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with other heterochromatin components to develop transcriptional gene silencing (TGS) 
(Buscaino 2019).  
 
Facultative heterochromatin islands in fission yeast are pinpointed through 
mapping the enrichment of H3K9 methylation in chromosomal euchromatin bodies 
(Zofall, Yamanaka et al. 2012). A subset of facultative heterochromatin islands, known 
as “determinant of selective removal” (DSR) islands, contains meiotic genes that can 
only express during meiosis. DSR islands are silenced through RNA degradation 
machinery by RNA elimination complex, together with heterochromatin Clr4 
associated transcriptional silencing (Zofall, Yamanaka et al. 2012). A recent 3D 
architecture analysis in Drosophila showed that membrane-less pericentromeric 
heterochromatin (PCH) domains interact with heterochromatin islands interspersed in 
euchromatin. It revealed the potential crosstalk between heterochromatin domains in 
space (Lee, Ogiyama et al. 2020). 
 
 
1.1.1.3 Chromatin dynamics  
Euchromatin and heterochromatin enable mutual conversion under the regulation 
of many factors, such as histone modification enzymes, ATP dependent chromatin 
remodelers, transcriptional factors (Figure 3) (Trojer and Reinberg 2007). These 
regulations can also be influenced by each other. According to our interests, we focus 
more on the heterochromatin side. Abolishment on RNAi dependent/ independent 
silencing machinery (detailed as discussed above) and correlated factors, can disrupt 
the assembly and maintaining of heterochromatin structure and turn it into active 
regions. Another way of the transition between heterochromatin to euchromatin is to 
disturb the heterochromatin spreading. 
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Figure 3. Euchromatin and Heterochromatin can mutually convert. The transition of chromatin 
compaction and transcription between these two types of chromatin is regulated by several types of 
factors, as mentioned in the illustration. It is adapted to the figure from Trojer and Reinberg 2007. 
 
In the 1930s, Muller described the position effect variegation (PEV) on eye color 
controlled gene in Drosophila melanogaster: the expression of the white gene located 
in euchromatin leads to the red eyes. Translocation of the gene near pericentromeric 
heterochromatin caused by chromosome rearrangement results in the transcriptional 
silence and the phenotype of mottled eyes (Muller 1930, Elgin and Reuter 2013). 
Another similar phenomenon was later observed in budding yeast Saccharomyces 
cerevisiae, where reporter genes became repressed by being placed in the region near 
telomeres, so-called telomere position effect (TPE) (Gottschling, Aparicio et al. 1990, 
Mondoux and Zakian 2006). Both PEV and TPE have been found in many other 
organisms, from plant to mammal, indicating that constitutive heterochromatin can 
spread its repressive state to the neighbor’s active genes (Dillon and Festenstein 2002, 
Elgin and Reuter 2013). This silencing expansion plays a crucial role in altering the 
transcription of regulatory genes during the cellular developmental process (Lippman, 
Gendrel et al. 2004). The abnormal heterochromatin spreading can also suppress the 
transcription of genes improperly and consequently induce disease (Kleinjan and 
Lettice 2008). 
 
 Consequently, cells have developed the structure of chromatin boundary in order 
to prohibit the expansion of heterochromatin to euchromatin. Generally, the boundary 
consists of particular DNA elements “insulator” flanking at heterochromatin domain 
and relevant proteins (Wei, Liu et al. 2005, Valenzuela and Kamakaka 2006, Wang, 
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Lawry et al. 2014). In S.pombe, transfer RNA (tRNA) gene and IRC element function 
as insulators in centromere (Matsuda, Asakawa et al. 2017). Transcriptional factor 
TFIIIC and Histone demethylase LSD 1 act virtually for the boundary of tRNA genes 
(Lan, Zaratiegui et al. 2007). Negative regulator of subtelomere Epe1 that has the 
histone demethylation JmjC domain and bromodomain protein Bdf2 for histone 
acylation are required to IRC element boundary (Buchanan, Durand-Dubief et al. 2009, 
Wang, Tadeo et al. 2013). 
  
 Inversely, wild type heterochromatin domains should also be protected to 
maintain its natural function. A chromatin remodeler Fun 30 protein Fft3 in S.pombe as 
an example, sits at tRNA and IRC elements boundaries of centromere and LTR element 
boundary of subtelomere to shield the expansion from euchromatin (Steglich, Strålfors 
et al. 2015). 
 
A recent study in S.pombe analyzed the heterochromatin proteins through Swi6-
associated proteome and euchromatin proteins through acetylated histone binding 
Bdf1/2 associated proteome. They revealed that euchromatin and heterochromatin 
proteomes have over-lapped proteins besides the fundamental chromatin component 
like histone proteins, but also unique proteins for each of them. If these shared proteins 
between heterochromatin and euchromatin help the inter-conversion is still unclear 
(Iglesias, Paulo et al. 2020). 
 
 
1.1.2 Histone modifications  
Post-translational modifications (PTM) usually occur at the N terminal tails of 
histone proteins, which play crucial roles in modulating chromatin structure and 
regulating gene expression. PTM on histones was firstly correlated to functional 
outcome in 1964 when Allfrey described his observation that high level of histone 
acetylation was relevant to the less inhibition of RNA synthesis (Allfrey, Faulkner et al. 
1964). Till now, many histone modifications, such as acetylation, methylation, 
ubiquitination, phosphorylation, ADP ribosylation, sumoylation, and even lactylation 
reported last year, have been found at various residues of different histone proteins. 
They are correlated with transcription switch on/off and consequently involved in 
diverse cellular processes (Kouzarides 2007, Zhang, Tang et al. 2019). Most of the 
histone modifications are dynamically regulated by “writer”-enzymes adding the 
modifying groups and “eraser”- enzymes removing the modifying groups (Nicholson, 
Veland et al. 2015). Here I list acetylation and methylation on residues of canonical H3 
and H4, together with their writers, erasers, and proposed function (Table 1). 
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Histone modifications carry out functions with two mechanisms mutually 
dependent or independent. 1) Some histone PTMs influence the chromatin structure 
directly through disturbing the electronegativity of the nucleosome. For instance, 
acetylation and phosphorylation reduce the positive charge through neutralizing the 
histone tail and introducing a negative charge respectively, which may disrupt the 
interaction between DNA and histones. Ubiquitination affects the architecture of 
nucleosome because of the large size of the multi-ubiquitins attachment. 2) Histone 
PTMs influence the chromatin structure indirectly through recruiting other factors 
(Bannister and Kouzarides 2011, Lawrence, Daujat et al. 2016). Some protein domains 
can specifically recognize and bind their target modified histones. For instance, PHD 
domain, chromodomain, tudor domain, and MBT domain bind to methylated lysine, 
while bromodomain binds to acetylated lysine. The proteins embracing these 
recognizing domains play diverse roles in modulating chromatin structure. For instance, 
it can be ATP-dependent chromatin remodelers, such as CHD1 with chromodomain 
targeting H3K4me2/3. It can be interactive chromatin factors, such as heterochromatin 
protein HP1 with chromodomain targeting H3K9me2/3. It can also be histone 
modifying enzyme itself, such as GCN5 of histone acetyltransferase HATs family 
targeting acetylated lysine on H4 (Sanchez and Zhou 2009, Bannister and Kouzarides 
2011, Yun, Wu et al. 2011).    
 
Histone modifications also affect each other (Figure 4). As an example, we have 
mentioned in the previous section that hypoacetylation from HDACs is essential for 
installing H3K9me3 in heterochromatin regions. Another example is H3K27me3 and 
H2AK119ub from the Polycom Repressive Complex (PRC), which we will discuss in 
detail later.    
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Histone 
Modified 
Residuals 
Modification  Writer Eraser Proposed Function 
H3 
Lys4 (S. 
cerevisiae) 
Acetylation Esa1, Hpa2 
Class I :HDAC1,2,3,8 /Rpd3 S. 
cerevisiae  /Clr6 S.pombe                                            
Class IIa :HDAC4,5,7,9 /Had1 S. 
cerevisiae/Clr3 S.pombe                       
Class IIb :HDAC6,10                   
Class III : SIRT1,6,7/Sir2 yeast 
transcriptional activation 
Lys9 Acetylation Gcn5, SRC-1 transcriptional activation, histone deposition 
Lys14  Acetylation 
Gcn5, PCAF, Esal, Tip60, SRC-1, 
Elp3, Hpa2, hTFIIIC90, TAF1, Sas2, 
Sas3, 
histone deposition, transcriptional activation, DNA repair , RNA 
polymerase II & III transcription 
Lys18 Acetylation Gcn5, p300/CBP transcriptional activation, DNA repair and replication 
Lys23 Acetylation unknown, Gcn5, SAs3, p300/CBP histone deposition , transcriptional activation, DNA repair 
Lys27 Acetylation Gcn5 transcriptional activation 
Lys56 (S. 
cerevisiae) 
Acetylation Spt10 transcriptional activation, DNA repair 
Lys4 Methylation 
Set1 (S. cerevisiae), MLL, ALL-1, 
SMYD,SET7/9, PRDM9 
Jhd2(S. cerevisiae), LSD, NO66, 
JARID1 
permissive euchromatin (di-Me), transcriptional activation 
Arg8 Methylation PRMT5 JMJD6 transcriptional repression 
Lys9 Methylation 
Suv39h,Clr4(S.pombe), G9a,GLP, 
SETDB1, PRDM family 
Rph1(S. cerevisiae), JHDM2, 
JHDM3, PHF8 
transcriptional silencing (tri-Me), transcriptional repression, genomic 
imprinting, transcriptional activation 
Arg17 Methylation CARM1 PAD4 transcriptional activation 
Lys27 Methylation Ezh2, G9a 
unkown, UTX, JMJD3, KIAA1718, 
PHF8 
transcriptional silencing, X inactivation (tri-Me) 
Lys36 Methylation 
Set2(S. cerevisiae), SET2D, NSD, 
SMYD2, ASH1L, SETD3 
JHDM1 and JHDM2 family transcriptional activation (elongation) 
Lys79 Methylation Dot1 unknown transcriptional activation (elongation), checkpoint response 
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Histone 
Modified 
Residuals 
Modification  Writer Eraser Proposed Function 
H4 
Lys5 Acetylation Hat1, Esal, Tip60, ATF2, Hpa2, p300 HDAC3 histone deposition, transcriptional activation, DNA repair 
Lys8 Acetylation 
Gcn5, PCAF, Esal, Tip60, ATF2, Elp3, 
p300 
Class I :HDAC1,2,3,8 /Rpd3 S. 
cerevisiae  /Clr6 S.pombe            
Class IIa :HDAC4,5,7,9 /Had1 S. 
cerevisiae/Clr3 S.pombe              
Class IIb :HDAC6,10                   
Class III : SIRT1,6,7/Sir2 yeast 
transcriptional activation, DNA repair 
Lys12 Acetylation Hat1, Esal, Tip60, Hpa2, p300 histone deposition, telomeric silencing, transcriptional activation, DNA repair 
Lys91 (S. 
cerevisiae)  
Acetylation Hat1/Hat2 chromatin assembly 
Arg3 Methylation PRMT1  PAD4 transcriptional activation 
Lys20 Methylation PR-Set7, Suv4-20h, Set9 (S. pombe) PHF8,PHF2 
transcriptional silencing (mono-Me), heterochromatin (tri-Me),transcriptional 
activation, checkpoint response 
Lys59 Methylation unknown, CK2 unkown mitosis, chromatin assembly, DNA repair 
 
Table 1.  Acetylation and Methylations on residues of canonical H3 and H4 was conclude in the table, together with the “writer” ,“eraser” and their proposed function. Most 
presented histone modification are conserved from human to yeast. Specie specific modification was labelled as in brackets(Nicholson, Veland et al. 2015, Hyun, Jeon et al. 
2017). 
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Figure 4 Crosstalk between histone modifications. Locations of each histone modification is as labeled 
in the figure. Arrow head represents positive effect, while flat head represents negative effect (Bannister 
and Kouzarides 2011). Reprinted by permission from Springer Nature Customer Service Centre GmbH. 
 
 
1.1.2.1 H3K9me2/3 
   H3K9 can be methylated with attaching 1/2/3 methyl groups. Different levels of 
methylated H3K9, as well as the genomic locations, have distinct functional outcomes. 
H3K9me1 abundant at promoters exert as a transcriptional activator, while H3K9me2 
and me3 enriched in silent region/gene bodies exert as a transcriptional repressor, and 
are proposed as conserved heterochromatin marks(Zhang, Cooper et al. 2015). 
 
   The methylation on H3K9 is loaded step-wise and is dependent on different histone 
methyltransferases (HMTs). In Caenorhabditis elegans, single deletion of MET2, the 
orthologue of human SETB1, results in reduced H3K9me1/2/3 (10~30% left), and 
single deletion of SET-25 results in lack of H3K9me3 but wild type level of 
H3K9me1/2. Deletions of both genes resulted in the elimination of all H3K9 
methylation marks. It indicates that H3K9 is mono-/di- methylated by MET2 and 
subsequently methylated by SET-25 for the third methyl group. This step-wise 
methylation is also involved in the process of a continuous self –reinforcing movement 
to perinuclear landing, suggesting potential alternative roles of H3K9m2 and me3 
(Towbin, González-Aguilera et al. 2012). In S.pombe, Clr4 is the only HMT on H3K9 
methylation. In vitro binding assay has shown the most binding affinities of its 
chromodomain to H3K9me3 compared to unmodified H3, H3K9me1/2 (Zhang, Mosch 
et al. 2008). Point mutations F449Y in the catalytic SET domain of Clr4 dramatically 
increased H3K9me2 level but almost lose H3K9me3 level at pericentromeric of fission 
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yeas. It reduces the enrichment of both me2 and me3, and a consequent silencing defect 
in the subtelomeric heterochromatin region. Surprisingly, the transcription of the 
pericentromeric region is active with enriched H3K9me2. It suggests distinct roles of 
H3K9me2 and me3 in RNAi machinery, and only H3K9me3 provides the real 
transcriptional gene silencing (Jih, Iglesias et al. 2017). However, in the wild type, how 
this step-wise methylation is regulated is still unclear. 
 
Study in human cells revealed that H3K9me2 demethylation is mediated by the 
Jumonji domain-containing 1A (JMJD1A) dimers also via two steps (Goda, Isagawa et 
al. 2013). In fission yeast, a higher rate of histone turnover that replaces modified 
histone by newly synthesized histones, is important for demethylation on H3K9. JimC-
domain protein Epe1 and RNA PolII associated complex PafC promote histone turnover 
in heterochromatin regions (Aygün, Mehta et al. 2013, Oya, Durand-Dubief et al. 2019). 
 
 
1.1.2.2 PRC complex  
Generally, polycomb proteins construct two complexes: Polycom Repressive 
Complex 1 (PRC1) and Polycom Repressive Complex 2 (PRC2). PRC2 complex 
consists of core members, including Embryonic Ectoderm Development factor 2 
(EED2), zinc finger protein SUZ12, histone methyltransferase EZH1/2, and other 
proteins, including histone deacetylase HDAC, histone chaperones RbAp46/48. Both 
EZH1 and EZH2 are responsible for tri-methylation on H3K27 (Margueron and 
Reinberg 2011, Aranda, Mas et al. 2015). Besides the core members, PCL, EPOP, and 
PALI1/2, as additional components, form non-canonical PRC2.1, while Jumonji family 
members associated with histone demethylation JARID2 and zinc finger protein 
AEBP2 constitute the non-canonical PRC2.2. The non-canonical PRC2 cooperate to 
affect global SUZ12 recruitment(Healy, Mucha et al. 2019).  
 
Canonical PRC1 complex is constituted of five subset proteins, including 
RING1A/B, PCGF, PHC, CBX, and SCM. Various non-canonical PRC1 have been 
reported. Beside RINGA/B and alternative PCGF proteins, non-canonical PRC 
complex harbor Ring1B-Yy1 binding protein RYBP or its homolog YAF2 together with 
distinct components (Figure 5) (Aranda, Mas et al. 2015).  
 
Ubiquitination on lysine 119 of H2A is not a conserved HTM in eukaryotes. Mono-
ubiquitinated H2AK119, known as a transcriptionally repressive mark, is accomplished 
by two E3 ubiquitin ligases: 2A-HUB, which is a RING finger protein, and RING1A/B, 
which is the core member of PRC1. However, it is reported that the repression caused 
by these two enzymes targets different genes. 2A-HUB can mono-ubiquitinate H2A 
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both in vivo and in vitro. Together with the N-Cor complex, 2A-HUB negatively 
regulates the transcription of a specific subset of chemokine genes in macrophages 
(Zhou, Zhu et al. 2008). H2AK119ub at the promoter-proximal regions prevents the 
recruitment of facilitates chromatin transcription (FACT) complex and blocks the RNA 
PolII release at the beginning of elongation (Van Kruijsbergen, Hontelez et al. 2015). 
PRC mediated H2AK119ub enforces an uncommon conformation at silent bivalent 
genes in embryonic stem cells. (Stock, Giadrossi et al. 2007). 
 
 
 
 
Figure 5 Components of canonical PRC1 complex (cPRC1) and non-canonical PRC1 complex 
(ncPRC1). The core complex can associate with distinct PCGF proteins to incorporate with alternative 
members, as illustrated. PCGF2 and PCGF4 in cPCR1/ncPRC1 recruit RYBF/YAF. PCGF3 and PCGF5 
are for PRC1.3 and PRC1.5, while PCGF1 is for PRC1.1 and PCGF6, is for PRC1.6. Reprinted with 
permission from AAAS (Aranda, Mas et al. 2015).  
 
The classical model of polycomb mediated repression is: PRC2 firstly introduces 
H3K27me3 at the target promoter region. CBX recognizes H3K27me3 to recruit PRC1 
that subsequently catalyze H2AK119ub. Moreover, methylation on H3K27 prohibits 
the acetylation in the same loci. In mammalian cells, the RNA of Xist in X chromosome 
initiates the recruitment of PRC2 and finalize the X chromosome inactivation. 
Chromatin enriched of PRC1 and PRC2 is scattered in the euchromatin but not 
heterochromatin in an overlapped or non-overlapped way (Sugiyama, Cam et al. 2005, 
Vidal and Starowicz 2017). The ncPRC regulates gene transcription more in an 
H3K27me3 independent way. For instance, histone demethylase KDM2B in PRC1.1, 
containing a DNA binding CxxC domain, can recognize the unmethylated CpG islands 
of active genes and consequently guides the recruitment of PRC1.1 (van den Boom, 
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Maat et al. 2016). A recent study showed that cPRC1 but not ncPRC1 potentially control 
the repression inheritance through genome replication and cell division(Moussa, Bsteh 
et al. 2019). 
 
The PRC complexes repress homeotic genes and play crucial roles in embryonic 
development, stem cell differentiation, as well as hematopoiesis. ncPRC1 has been 
shown to dynamically accumulate during neural cell development. For instance, 
PRC1.6 is most abundant in the embryonic stem cells (EMCs), and decreases following 
the differentiation to neural progenitor cells (NPCs). PRC1.5 exhibits the opposite 
abundancy trend. In humans, the misregulation of the PRC complex occurs in many 
cancers (Loubiere, Martinez et al. 2019).  
 
 
1.1.3 ATP dependent chromatin remodelers  
 
The chromatin remodelers are enzymes that can hydrolyze ATP to regulate 
chromatin structure through several mechanisms: Nucleosome unwrapping, 
nucleosome repositioning/spacing, nucleosome ejection, histone eviction or exchange 
of histone variants (Lorch, Maier-Davis et al. 2010). Most chromatin remodelers share 
a conserved ATPase domain harbored by RNA/DNA helicase superfamily 2. According 
to the non-catalytic domains and functional analysis, chromatin remodelers have been 
categorized as four subfamilies: imitation switch (ISWI), chromodomain helicase 
DNA-binding (CHD), switch/sucrose non-fermentable (SWI/SNF) and INO80 (Figure 
6) (Clapier, Iwasa et al. 2017). Remodelers in SWI/SNF family contain a HSA 
(Helicase-SANT) domain located at N-terminal and a pair of bromodomain at the C -
terminal. The HAS domain is predicted to bind DNA, and the bromodomain, as 
mentioned, recognizes acetylated histone tails. ISWI protein contains a HAND-SANT- 
SLIDE (HSS) domain located at C-terminal, which binds to unmodified H3 and linker 
DNA. CHD family is characterized by the two tandem chromodomains presenting at N 
terminal of protein. A regulatory coupling region that can negatively regulate 
remodeling function of enzyme, resides adjacent ATPase domain. Similar to the 
SWI/SNF family, Ino80 also owns an HSA domain at N-terminal, while the large 
insertion between the two sub-domains of ATPase is various at length through species. 
INO80 promotes the exchange of H2A-H2B canonical dimers by variant H2A.Z-H2B, 
mediated by SWI2/SNF2-related protein p400, SWR1 chromatin remodeling complex, 
and Snf2-related CBP activator protein (SRCAP) complex (Clapier and Cairns 2009, 
Clapier, Iwasa et al. 2017).  
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Figure 6. Domain components of four chromatin remodeler families. All four families shared 
catalytic ATPase-Translocase domain (Tr) contains two-lobe subdomains with small or large insertions. 
Remodelers can be classified into four subfamilies based on their domain organization. Domains marked 
here are as explained in the above text section. NegC* in CHD family is structurally similar to the ISWI 
negative regulator of coupling (NegC) in ISWI (Clapier, Iwasa et al. 2017). Reprinted by permission 
from Springer Nature Customer Service Centre GmbH. 
 
 
1.1.3.1 CHD chromatin remodeling family 
The CHD remodelers, existing in all eukaryotic species, facilitate chromatin 
compaction and positive or negative gene transcription. Hence the remodelers are 
essential for many fundamental cellular processes, such as DNA repair, cell 
proliferation, and cell development. The loss or misfunction of CHD remodelers 
presents in many developmental diseases and cancers (Riedmann 2012).  
 
Members of CHD family can be further categorized into three classes, including 
CHD1-2 for class I, Mi2/NURD (CHD3-5) for class II and CHD6-9 for class III 
(Murawska and Brehm 2011, Mills 2017). ScCHD1 (S.cerevisiae CHD1) is the only 
CHD remodeler in the budding yeast, while fission yeast has three: Mit1, Helicase-
Related protein 1 and 3(Hrp1 and Hrp3) (Längst 2013). CHD1 remodeler is featured by 
an extra DNA binding domain at C-terminal to interact with AT-rich DNA sequences 
CHD3-5 belongs to the Mi2/NURD subfamily and contain two particular PHD (plant 
homeodomain) zinc finger located at N-terminal side of chromodomain, which can bind 
to methylated histones as mentioned before. Class II CHD remodelers are also featured 
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by domains at C-terminal for unknown function (DUF). Class III subfamily member 
contains a SANT motif for DNA binding and a tandem BRK (Braham and Kismet) 
domain at the C-terminal (Clapier, Iwasa et al. 2017). 
 
 
1.1.3.1.1 CHD1 and CHD2 
Human CHD1 is recruited to the active chromatin via interacting H3K4me2/3 with 
its chromodomain. H3K4me2/3 abounds in the transcriptional start site (TSS) of the 
active gene, as well in the coding region. The CHD1 binds to H3K4me3 enriched region 
to attach SNF2H, the FACT complex, the transcriptional elongation associated PAF 
complex as well as the U2 snRNP complex, and hence enhance the pre-mRNA splicing 
and transcriptional elongation (Sims III, Millhouse et al. 2007). The function of CHD2 
is highly correlated to CHD1. The coupled recruitment of CHD1 and CHD2 regulates 
the chromatin accessibility and histone H3/H3.3 occupancy at active chromatin regions 
(Siggens, Cordeddu et al. 2015). CHD1 is required for embryonic stem cell ECS 
differentiation, while CHD2 determines myogenic cell fate via deposition of H3.3. It 
has been shown that inactivation of CHD1 and CHD2 occurs in prostate cancer and 
leukemia, respectively (Mills 2017). 
 
CHD1, together with ISW1, is required to maintain the regular nucleosome 
spacing around promoters in budding yeast. ScCHD1 lacks several conserved residues 
in chromodomain and hence cannot bind H3K4me3. It recruits to transcriptionally 
active genes via interacting with elongation factors Spt4-Spt5 proteins, Paf1, and FACT 
(Mills 2017, Lin, Du et al. 2020). Both human CHD1 and ScCHD1 regulate cohesion 
and hence affect the chromatin compaction (Boginya, Detroja et al. 2019). Some studies 
showed that CHD1 is a component of conserved HAT complex SAGA-SLIK that favors 
H3 acetylation and H2B de-ubiquitination (Pray-Grant, Daniel et al. 2005). The 
chromodomains in ScCHD1 block their ability to use DNA as substrate in order to 
maintain the targeting preference of nucleosome (Hauk, McKnight et al. 2010). A small 
region (named coupling region) between ATPase and the DNA binding domain affect 
the nucleosome spacing function of ScCHD1 but not nucleosome assembly. This 
observation offers the hypothesis that the remodeling process of ScCHD1 is divided 
into two sequential steps, promoting nucleosome assembly and exerting nucleosome 
spacing, both of which are ATP dependent (Torigoe, Patel et al. 2013). In the fission 
yeast, human CHD class I has two orthologues Hrp1 and Hrp3, and both of them 
promote the nucleosome positioning in the coding region and inhibit the cryptic 
transcription (Pointner, Persson et al. 2012, Touat‐Todeschini, Hiriart et al. 2012).  
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1.1.4 Mechanisms of nucleosome assembly and remodeling 
In vitro, nucleosomes can be spontaneously assembled onto a DNA molecule with 
supplied histone octamers. This process is based on the contract charge properties of 
DNA and protein. In vivo, two significant factors are involved in the nucleosome 
assembly/disassembly in eukaryotic cells:  
1) Histone chaperone, such as nucleosome assembly protein 1 (Nap1) in S.pombe 
(Andrews, Chen et al. 2010)  
2) ATP dependent motor proteins, which do not only promote nucleosome 
assembly via wrapping DNA around the histones but also remodel chromatin by altering 
the positions of nucleosomes along with the DNA, such as CHD1(Torigoe, Patel et al. 
2013).  
 
   Although the remodelers variously affect the nucleosome/chromatin, they still share 
some standard features related to their conserved snf2-like ATPase domain that contains 
two RecA-like lobes (DExx, lobe 1; HELICc, lobe 2). They all prefer to use 
nucleosomes as substrates rather than DNA. Based on the conserved catalytic domain, 
one shared DNA translocation mechanism was discovered: Both RecA-like lobes 
(translocase domain) in ATPase domain bind superhelical location 2 (SHL2) of DNA 
in a nucleosome (two DNA helical turns away from the nucleosome dyad). Once bound 
to the SHL2, the translocase domain performs a DNA translocation with direction 3’ to 
5’ by dragging in DNA from the proximal side of the nucleosome (the DNA entry site, 
∼50 bp from the translocase) and pushing it towards the distal side (the DNA exit 
site,∼97 bp from the translocase). DNA translocation exerts this process via creating 
loops on the naked DNA strands with superhelical torsion at both sides of the 
translocase domain. The translocase domain keeps on attaching to the octamer during 
DNA translocation, probably through a histone-binding domain (HBD). In SWI/SNF, 
the HBD domain is known as Snf2 ATP coupling (SnAC). In ISWI and CHD, the HBD 
domain resides within the ATPase domain (Deindl, Hwang et al. 2013, Clapier, Iwasa 
et al. 2017). 
 
   The shared DNA translocation mechanism is regulated by alternative non-catalytic 
domains in remodelers and associated proteins to achieve different outcomes. For 
instance, the actin-related protein (ARP) module, as HAS and post HAS domains in 
SWI/SNF, facilitates nucleosome ejection. The position of the neighbor nucleosome is 
important for nucleosome spacing in the ISWI family that determines the length of the 
linker DNA by HSS domain (Struhl and Segal 2013, Clapier, Iwasa et al. 2017). Recent 
electron microscope (EM) studies revealed the architecture of the nucleosome-bound 
CHD1 structure, suggesting that CHD1 binds to nucleosomes through the DBD domain 
on linker DNA and ATPase domain on SHL2 (Lin, Du et al. 2020). It creates a twisted 
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DNA translocation in ATP-bound states. These studies explain the previous observation 
of nucleosome sliding towards the center position by CHD remodelers in vitro assays. 
This property finally generates the nucleosome array on chromatin (McKnight, Jenkins 
et al. 2011). 
 
 
1.2 Fission yeast Schizosaccharomyces pombe 
Fission yeast has been utilized in the lab since the 1950s as a model organism for 
investigating various eukaryotic cellular and molecular functions. The studies based on 
S.pombe are driven by its conserved biological processes, some of which have been lost 
in budding yeast Saccharomyces cerevisiae. Fission yeast is a unicellular eukaryotic 
organism that is ~7–14 µm long and ~4 µm wide. It proliferates via medial cell fission. 
The cell cycle of wild type fission yeast is rapid with generation time in vegetative 
growth around 2 hours at normal culturing temperature 30°C in complex and minimal 
media. Fission yeast cells produce mating types with relevant genotypes: h+ and h- cells, 
which produce P factor and M factor respectively. Both of P and M factors are mating 
pheromone that can stimulate associated downstream pathways in order to induce 
the sexual agglutination and crossing (Seike, Nakamura et al. 2013). When there is 
limited nutrition in the environment, yeast cells will arrest in the G1 phase of the mitotic 
cell cycle. h+ and h- cells conjugate to form a diploid zygote. If the nutrition/nitrogen 
is re-supplied in this step, the diploid zygote will go back to the mitotic cell cycle. 
Otherwise, it will continue with the meiotic cell cycle (Hayles and Nurse 1989, Hayles 
and Nurse 2018). 
 
S.pombe has a small genome around 14MB, consisting of three chromosomes that 
harbor a total of 2510 protein-coding genes with 5300 introns (Chikashige and Hiraoka 
2002). Genome organization of S.pombe shares several conserved features with higher 
eukaryotes compare to budding yeast, such as regional centromere, and similar telomere. 
Subtelomeric regions reside at both ends side of Chromosome I and II, but not 
chromosome III (rDNA). As we discussed above, heterochromatin in S.pombe is 
assembled and maintained via RNAi dependent and independent machinery, which is 
also similar to human. RNA splicing complex and process is also more similar to human 
compared to budding yeast. Because of the small genome, the mating phenomenon, and 
rapid growth, fission yeast cells are easy to genetically manipulate for required methods 
and studies (Muers 2011, Fair and Pleiss 2017, Hayles and Nurse 2018).  
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1.3   Hematopoietic development 
  
1.3.1 Hematopoiesis 
    Hematopoiesis is the developmental process of continually producing 
differentiated blood cells from hematopoietic stem cells (HSCs) with various functions, 
such as oxygen transferring and immune defense. In adults, HSCs are found in the bone 
marrow (BM), and are characterized by self-renewal capacity. It generates all lineages 
of blood cells. The differentiation of HSCs follows two major lineages—Myeloid and 
lymphoid. HSCs produce common myeloid progenitors (CMP) and common lymphoid 
progenitors (CLP). Myelopoiesis initiates from CMP and produces megakaryocytes, 
erythrocytes, mast cells, and myeloblasts that latter differentiate into 
monocytes/macrophages and granulocytes- basophil, neutrophil, and eosinophils. 
Granulocytes are a group of white blood cells in the immune system and characterized 
by the presence of granules in their cytoplasm and polymorphic nuclear. Lymphopoesis 
initiates from CLP and finally differentiates into matured lymphocytes that mainly 
locate in lymph, including natural killer cells, T cells, and B cells (Figure 7). However 
recent single-cell omics profiling reveals heterogeneity of HSCs and progenitors 
(Ceredig, Rolink et al. 2009, Zhang, Gao et al. 2018). 
    
The developmental fate and lineage choice in hematopoiesis are influenced by 
diverse sets of cytokines, chemokines, receptors, and intracellular signaling molecules. 
Some transcriptional factors can regulate the development of hematopoietic cells, such 
as GATA-1 for erythropoiesis and PU.1 for myelopoiesis (Burda, Laslo et al. 2010). 
Transcriptional factors BACH 1/2 are associated with the lineage direction of erythroid-
myeloid progenitors and lymphoid-myeloid progenitors as a response to the 
environmental changes (Kato and Igarashi 2019). Presence of different CD (cluster of 
differentiation) markers on the cell surface are used to characterize the cell fates. Taking 
myeloid lineage as an example: CD34+/38- for HSCs, CD34+/127+ for CMPs, 
CD41+/42+ for megakaryocytes, and CD11B+/13+/16+/18+ for matured granulocytes 
(Altiındağ and Baykan 2017).   
 
 
22 
 
 
 
Figure 7. Classical hematopoietic hierarchy. Blood cell differentiation initiates from multi-potential 
hematopoietic stem cells and evolves into two major lineages-myeloid and lymphoid. Hematopoietic 
stem cell generates common myeloid progenitors, which differentiate into mature megakaryocytes, 
erythrocytes, basophils, neutrophils, eosinophils, monocytes /macrophages, and common lymphoid 
progenitors, which differentiate into mature nature killer cells, T cells and B cells. Reuse permission from 
A. Rad and M. Häggström. CC-BY-SA 3.0 license. 
 
 
1.3.2 Epigenetics of hematopoietic development 
Epigenetics are changes that can switch on/off gene transcription without altering 
the DNA sequences. Several epigenetic mechanisms have been described, including 
DNA methylation, histone modification, chromatin remodeling by remodeling enzymes, 
and RNA interference (Weinhold 2006).  
 
In general, global DNA methylation changes dynamically during hematopoietic cell 
development. Overall, the methylation level increase during lymphoid differentiation, 
while erythroid development is more associated with reduced global methylation (Ji, 
Ehrlich et al. 2010, Farlik, Halbritter et al. 2016). CpG methylation at developmental 
regulatory genes’ promoters is the critical epigenetic regulation in both lineage-choice 
and differentiation within hematopoiesis. For instance, DNA 
methylation/demethylation patterns present for activating lineage-specific genes also 
exists to suppress transcription of other lineages (Hodges, Molaro et al. 2011). DNA 
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methylation also involves in regulating the sensitivity to differentiation factor through 
methylation in the downstream regulatory sites of crucial transcriptional factors, such 
as the binding site of GATA-1, RUNX1 (Suzuki, Shimizu et al. 2017). DNA methylation 
in human is carried out by sets of DNA methyltransferases: DNMT1, DNMT3A, and 
DNMT3B. DNMT3A and DNMT3B are responsible for methylated CpG while Dnmt1 
is responsible for maintaining the existing DNA methylation (Okano, Bell et al. 1999). 
DNMT3A is ubiquitously expressed throughout the differentiation. Loss of DNMT3A 
in HSC results in increased self-renewal capacity and decreased differentiation capacity, 
but fewer changes are caused by loss of DNMT3B. The loss of DNMT1 disrupts the 
self-renewal and multiple differentiation potency in long term HSC that has extensive 
self-renewal capacity (Trowbridge, Snow et al. 2009, Sashida and Iwama 2012). 
   
     The DNA oxidation also regulates global DNA methylation patterns via TET 
enzymes.TET1/2/3 catalyze 5-methyl-cytosine (5mC) conversion to 5-hydroxymethyl-
cytosine (5hmC), and to further oxidation products. This process finally leads to DNA 
demethylation through the thymine DNA glycosylase (TDG) - base excision repair 
(BER) pathways. Normally, TET1 and 3 promote 5hmC at promoters and prohibit 
DNMT activity (Rasmussen and Helin 2016). TET1 is highly expressed in ESCs, TET2 
and TET3 are more expressed in differentiated myeloid cells. In mice, disruption of 
TET2 results in enhanced self-renewal and proliferation ability. The differentiation 
without TET2 in HSCs is also towards myeloid lineage. TET2 and DNMT3A may co-
function to limit the expression of HSC genes but to activate the expression of the 
lineage-specific gene, such as KLF4 for erythroid differentiation (Sashida and Iwama 
2012, Goyama and Kitamura 2017). 
 
Histone modifications regulate transcription of lineage-specific genes. For 
instance, differentiation from CMP is found coupled with HDAC1 repression by 
CCAAT/enhancer-binding proteins during myeloid differentiation and HDAC1 
activation by GATA binding protein GATA-1 during erythro-megakaryocytic 
differentiation (Wada, Kikuchi et al. 2009). Double deletion of H3K9 methyltransferase 
SUV39H1 and SUV39H2 in HSC results in reduced stem cell function and drives the 
differentiation towards myeloid development with reduced lymphoid output (Keenan, 
Iannarella et al. 2020). PRC1 and PRC2 facilitate hematopoiesis and self-renewal for 
HSCs (Sashida and Iwama 2012).  
 
Chromatin remodelers are also involved in hematopoiesis regulation. For example, 
the chromatin remodeling subunit Baf200 facilitates normal hematopoiesis and 
suppresses leukemogenesis, through regulation erythropoiesis- and hematopoiesis-
associated genes (Liu, Wan et al. 2018).  
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1.3.3 Disorders of hematopoietic development  
Hematologic malignancies can occur at any stage of hematopoiesis and can 
produce dysfunctional blood cells and defects of the immune system or susceptibility 
to uncontrolled bleeding. Disruption of hematopoietic differentiation can produce three 
main types of blood cancer: leukemia, lymphoma, and myeloma. For leukemia, 
abnormal white blood cells or poorly differentiated cells are massively produced in the 
bone marrow, resulting in the accumulation of immature dysfunctional leukemic cells 
in the blood. According to the lineages of the neoplastic cells, leukemia is categorized 
as acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute 
lymphocytic leukemia (ALL) and chronic lymphoid leukemia (CLL) (Hu and 
Shilatifard 2016). 
      
1.3.3.1 Epigenetic changes in AML 
    Acute myeloid leukemia (AML) is a common blood malignant disease of the 
myeloid lineage of hematopoietic cells. It is distinguished by the block of myeloid 
lineage differentiation and abnormal accumulation of immature cells. Genetic 
mutations of epigenetic modifiers that can affect myeloid differentiation is one of the 
core aberrances leading to the disease. These epigenetic factors are involved in the 
mechanisms of DNA methylation, histone modification, chromatin remodeling enzyme 
or associated factors, and chromatin structure factor such as cohesion (DiNardo and 
Cortes 2016).  
 
DNMT3A is frequently mutated in many different types of hematopoietic diseases. 
Over 20% de novo AML harbor this mutation. Most frequent DNMT3A mutation in 
AML is R882H or R882C, which abolishes enzyme activity and DNA binding. It results 
in a particular pattern of abnormal DNA methylation, which consequently damages the 
function of HSCs, enhances self-renewal, and blocks differentiation (Huang, Ma et al. 
2013). DNMT3A dysfunction co-appears with a mutation on nucleophosmin (NPM1), 
FLT3-ITD or isocitrate dehydrogenase 1 (IDH1). Inactivation of TET2, resulting in 
increased 5mC levels but low levels of 5hmC, is present in 10~20% AML, but in over 
50% in CML (Pratcorona, Abbas et al. 2012, DiNardo and Cortes 2016, Goyama and 
Kitamura 2017, Koya and Kurokawa 2018).  
 
The mutations of IDH1-R132, IDH2-R140, and IDH2-R172 occur in ∼20% of 
AML with increased occurrence with age. Isocitrate dehydrogenase 1 and 2 (IDH1/2) 
proteins exert the oxidative decarboxylation of isocitrate to α-ketoglutarate. Mutant 
IDH proteins convert α-ketoglutarate into the oncometabolite 2-hydroxyglutarate, 
which limits α-ketoglutarate dependent enzymes, including TET2 for DNA 
hydroxymethylation, histone demethylase such as H3K9 demethylase 
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KDM4C (Geisbrecht and Gould 1999, Ward, Patel et al. 2010, Hu and Shilatifard 2016, 
Goyama and Kitamura 2017).  
 
EZH2 facilitates in leukemogenesis. Mutation of EZH2, as well as mutations on 
other PRC2 members, caused lack of H3K27me3 and repression defect on the target 
genes, EZH2 mutations have been frequently reported in Myelodysplastic syndrome 
(MDS) and T cell acute lymphoid leukemia (T-ALL). Last year, EZH2 mutations were 
reported as a new prognosis marker together with FLT3 and IDH2 mutations in AML 
patients (Mechaal, Menif et al. 2019). Gain-function-mutation or overexpression of 
EZH2, causing hypermethylation on H3K27, has been reported in natural killer/T cell 
(NKT) or B cell lymphoma(Lund, Adams et al. 2014). Epigenetic factor ASXL1 is 
associated with PRC mediated gene repression via recruiting PRC2 to the target locus. 
Mutation of ASXL1 in AML, usually occurred as C-terminal truncation, promotes 
myeloid transformation through disrupting PRC2 mediated gene repression (Eriksson, 
Lennartsson et al. 2015, DiNardo and Cortes 2016) 
 
    In AML, mutations are also found in genes of chromatin remodelers and structure 
factors that regulate downstream gene transcription through altering 
nucleosome/chromatin structures. BAF250A is one of the central members of the 
chromatin remodeling BAF complex. Mutant BAF250A has been reported in ~0.5% 
AML (Network 2013). Another chromatin structure modifier is cohesin, which is the 
protein complex facilitating sister chromatid cohesion, homologs recombination. It can 
form the chromatin loop together with CTCF and regulate associated gene expression 
(Wutz, Várnai et al. 2017). Mutation of cohesion has been reported in 5%-13% AML 
(Eriksson, Lennartsson et al. 2015). 
. 
Cytogenetic abnormality (chromosomal rearrangement), such as RUNX1-
RUNX1T1, MLLT3-MLL, MLL-AF9, is observed in over 50% the AML patients. The 
fused histone methyltransferases MLL proteins catalyze on wrong target genes and 
consequently cause aberrant gene transcription (Wang, Lin et al. 2009, Yang and Ernst 
2017).  
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2. Aim of The Thesis 
The thesis aims to explore the chromatin organization and related transcription in 
models of the fission yeast and human hematopoietic development. 
 
Study I: Investigate the novel role of Abo1 in the silencing of different types of 
heterochromatin in S.pombe and understanding the mechanism of H3K9me2/3 
establishment in heterochromatin regions 
 
Study II: Identify functional role of non-catalytic domain of chromatin remodeler in 
chromatin remodeling process via in vitro assays. 
 
Study III: Study the usage of alternative TSS causing protein domain exclusion and 
the functional consequences in hematopoietic cells. 
 
Study IV: Identify novel roles of epigenetic regulators in hematopoietic differentiation.         
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3. Methods 
In this thesis, multiple approaches were applied to explore the chromatin structure 
and functional consequences in the models fission yeast and human hematopoietic cell 
lines. Here we discuss some of the used methodologies. The specific conditions used in 
each method and experiment are shown in manuscripts. 
 
 
3.1 Cell culture  
Two models were applied for culturing in the studies for this thesis: fission yeast 
Schizosaccharomyces pombe and human hematopoietic cell lines. 
 
The fission yeast has been established and utilized as a great laboratory model to 
study chromatin structures. The yeast cells were cultured in the full nutrition medium 
(YES medium) with the components of yeast extract (5 g/l), glucose (20 g/l), and 
supplements: 225 mg/l adenine, histidine, leucine, uracil, and lysine hydrochloride. 
Special conditions were introduced according to required experiments, such as 
antibiotics/chemicals for strain selection with particular genotypes, limited nitrogen 
media for inducing crossing to generate the target genotype. The typical growing 
temperature for yeast culture is 30°C, while the heat and cold induction to examine the 
environmental stress response are performed at 37°C and 25°C. Fission yeasts with 
various genotypes were applied in study I and II 
 
Hematopoietic human cell lines used in the studies include the Jurkat cell line 
(ATCC® TIB-152™) and the K-562 cell line (ATCC® CCL-243™), which were 
applied in study III and IV. K562 cell line is derived from the bone marrow of a 53-
year-old female chronic myelogenous leukemia (CML) patient in blast crisis. It is a 
suspension cell line cultured in Iscove’s Modified Dulbecco’s Medium (IMDM) with 
10% fetal bovine serum. The K-562 cells were characterized as a multi potential 
leukemia cell line similar to the early-stage of erythrocytes, granulocytes, and 
monocytes. K-562 cells can be induced to megakaryocytic differentiation by phorbol 
12-myristate 13-acetate PMA treatment (Huang, Zhao et al. 2014). Jurkat cell line is 
derived from the peripheral blood of a 14-year-old boy with T-cell leukemia. It is a 
suspension cell line cultured in RPMI-1640 medium with 10% fetal bovine serum. 
 
 
3.2 Chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) is a method widely used for the 
identification of genome-wide locations of binding of various transcriptional factors, 
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histones, and other chromatin interacted proteins in vivo. Generally, DNA and 
interacting protein are cross-linked by a cross-linking agent such as formaldehyde. The 
cross-linked chromatin is then sonicated into segments approximately 300-500bp. The 
fragments bound the target protein are captured by a specific antibody that is then pulled 
down with protein A/G coated beads. Unspecific binding is washed away using 
different washing buffers. The cross-link of the antibody-protein-DNA complex is then 
reversed by incubation at 65°C together with a proteinase. With additional clean-up 
steps, the ChIP DNA is eluted and analyzed by different methods, such as qPCR or 
Next-generation sequencing.  
  
ChIP-sequencing (ChIP-seq) is a well-established and popular method to analyze 
the genome-wide enrichment of a chromatin-binding protein. Briefly, after the ChIP 
experiment, adaptors with index sequences are ligated to both ends of the eluted DNA 
fragments. Adaptor ligated fragments are subsequent amplified to prepare the ChIP 
DNA library. Hybridization happens in a flowcell between the library fragments and 
immobilized oligos with complementary sequences to adaptor regions. It triggers the 
bridge amplification and cluster generation. Next, fragments are sequenced by DNA 
synthesis with fluorescent-tagged nucleotides. Distinct fluorescent signals represent the 
read sequences. Mapped sequences to the reference genome reflect locations for the 
target protein. Together comparison with the enrichment of other factors, such as 
epigenetic marks, it makes ChIP-seq an excellent method to understand potential 
function and mechanism of the target protein (Buermans and Den Dunnen 2014). In our 
studies, eluted ChIP DNA was sent to our core facility BEA (http://www.bea.ki.se/), for 
library preparation and sequencing. 
 
 
3.3 Overall gene expression analysis 
In our studies, different methods were used to explore the overall gene expression, 
including RNA-microarray, RNA-sequencing, and cap analysis of gene expression 
(CAGE).   
 
RNA-microarray 
A microarray is a laboratory tool containing a slide with a fixed microscopy DNA 
probe that can hybridize with nucleotide sequences of the target. Total RNA molecules 
are extracted, reverse-transcribed, and labeled with a fluorescent dye. The 
complementary hybridization between cDNA fragment and the fixed probe can produce 
colored signals on the microarray slide. After hybridization, the microarray is scanned 
to measure the signals reflecting the expression of each gene printed on the slide. These 
slides, referred as gene chips or DNA chips, are utilized to detect gene expressions -- 
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transcriptome or the set of messenger RNA (mRNA) transcripts expressed by a group 
of genes (Sealfon and Chu 2011). Each chip allows measuring more than one sample 
by labeling the cDNA with distinct dyes, which make it valuable for comparing the 
expression of the same gene in different cells/conditions. In study I, for S.pombe, we 
applied RNA microarray in the multiple samples (different genotypes with alternative 
culturing conditions) by using the GeneChip 1.0FR array from Affymetrix. It is a tilling 
array, which means the probes cover the whole fission yeast genome, even the silent 
centromere region. The length of the probe is 25bp, with an overlap of 5bp. 
 
RNA-sequencing 
RNA sequencing (RNA-seq) is a high-throughput technique to examine the 
quantity and sequences of extracted RNA molecules by using next-generation 
sequencing (NGS). It is now another common method in the lab to analyze the overall 
transcriptome (Wang, Gerstein et al. 2009). In study III and V, after purification of total 
RNA from cells. Illumina TruSeq Stranded RNA assays were applied, which includes 
mRNA isolation, cDNA synthesis, ligations of adapters, and amplification of index 
libraries. The libraries were sequenced using Illumina Nextseq 550, generating 75bp 
single-end reads. Furthermore, the output reads were aligned to the human genome 
Refseq (hg38/GRCH38). After removing the repetitive and fuzzy regions, mapped 
reads offered the informative over-all gene expression. RNA sequencing is favored for 
its high dynamic range, detectability of RNA splicing, and single nucleotide 
polymorphism identification. However, the disadvantages are also very obvious for its 
high cost, the complexity of analysis (Altiındağ and Baykan 2017). 
 
CAGE 
     In study III, we aim to study the distribution of alternative TSS usage over a wide 
range of primary cells. Therefore, data obtained with Cap Analysis of Gene Expression 
(CAGE) that only measure a small fragment from the 5’-end of mRNA is perfect for 
this study. 
  
     Cap Analysis of Gene Expression (CAGE), developed by RIKEN in Japan, is a 
high throughput method to analyze transcriptome via measuring the sequence tags 5’ 
ends of mRNA at the cap sites and thereby identifying the transcriptional starting site. 
Briefly, RNA is extracted from cells and then reversed transcribed into first-strand 
cDNA with an oligo dT and random primer mix. The full-length cDNA is then picked 
out by biotinylated cap-trapper. The linker sequence contains restriction enzyme 
digestion sites of XhoI or I-CeuI or XmaJI, and MmeI. Additional upper single-stranded 
overhang oligonucleotide GN5 (GNNNNN) is also designed in the linker sequence. 
GN5 can subsequently be ligated to the single-strand full-length cDNA and is used to 
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synthesis of the second strand. The double-stranded cDNA is cleaved by enzyme MmeI, 
which creates a 2bp overhang at the cleavage site. The second linker sequence, which 
contains the XbaI site, ligates to the 2bp overhang. Streptavidin beads separate the 
ligation product via linking to the biotin at the 5’end of the fragment. PCR amplifies 
the purified 5’end tag. The tags are then sequenced and matched to the reference 
genome (Figure 8) (Shiraki, Kondo et al. 2003). CAGE shows accurate gene expression 
through detecting TSS but not gene body, and consequently offer information for 
prediction of transcriptional factor binding motifs. It is also can be used for detection 
of short enhancer RNA (eRNA) that usually expresses at every low level. 
 
In the FANTOM 5 project (https://fantom.gsc.riken.jp/5/), researchers have 
systemically investigated the TSSs using the CAGE method in ~400 distinct cell types. 
In study III, we used the CAGE data from FANTOM 5 project to study the alternative 
TSS usage in different cell types.  
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Figure 8. Schematic procedure of the CAGE protocol as detailed in Methods (Shiraki, Kondo et al. 
2003). Copyright (2020) National Academy of Sciences 
 
 
3.4 Biochemical assays in vitro 
In study II, a series of in vitro biochemical assays were performed in fission yeast 
to identify the functional roles of specific domains in our protein of interest. The in vitro 
assays include histone protein expression and purification, histone octamer 
reconstitution, nucleosome reconstitution, affinity purification and in vitro ATPase 
hydrolyzing activity. Methods performed for these in vitro assays such as plasmid 
construction, inclusion body extraction, gel filtration, DNA amplification, and High-
performance liquid chromatography (HPLC). HPLC is a technique for separating a 
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mixture of compounds (proteins in our study) by pumping the mixture-dissolved 
resolvent (mobile phase) at a high-pressure condition through a column filled with solid 
packing materials (stationary phase). Different components in the mixture interact 
differently with the stationary phase, which results in distinct flow rates and consequent 
components separation. The ATPase activity assay was performed with isotope Pi 
labeled ATP. The percentage of released labeled Pi represented the capacity of ATP 
hydrolysis with various substrates. Details of these biochemical assays were described 
in the manuscript. 
  
3.5 siRNA knocking down 
Gene knockdown is a common technique that decreases the expression of one gene 
(or several genes) via modifications on DNA or RNA level. RNA interference knocking 
down is the method of reducing gene transcription by introducing the small double-
stranded siRNA. Once this exogenous siRNA is transfected into cells, it will 
complementarily bind to the target mRNA and trigger the recruitment of RNA-induced 
silencing complex. Consequently, it leads to the degradation of mRNA. This method is 
widely utilized in the lab to study gene function. In our study III, we used siRNA was 
transfected by using NeonTM Transfection system to knockdown different potential 
transcripts to study the functional consequences caused by potential alternative 
transcripts from alternative TSS usage. 
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4. Results and Discussion 
 
4.1 Study I: Abo1 is required for the H3K9me2 to H3K9me3 transition in 
heterochromatin   
Constitutive heterochromatin and facultative heterochromatin, which are featured by 
di-/tri- methylated H3K9 and associated heterochromatin protein HP1, are relied on 
different silencing machinery. In study I, we investigated the role of the conserved 
bromodomain AAA-ATPase Abo1 in the heterochromatin regions of the fission yeast 
model, Shizosaccharomyces pombe.  
 
In this study, we first investigated the involvement of Abo1 in different aspects of 
heterochromatin assembly through performing Synthetic Genetic Array (SGA) assay, 
in which a small library containing 711 single gene deletion strains crossed with abo1∆ 
strain. The strongest negatively genetic interactions were observed between Abo1 and 
heterochromatin factors, including Clr3, Clr4, and Swi6. Interestingly, transcriptomic 
analysis reveals significant changes at heterochromatin regions between wild type and 
abo1-depleted mutant. Deletion of abo1 caused transcription silencing defect at both 
pericentromeric and subtelomeric heterochromatin regions. We subsequently examined 
the H3K9me2 and H3K9me3 heterochromatin marks in abo1∆ cells compared with 
wild type. Deletion of abo1 caused an increased H3K9me2 and reduced H3K9me3 at 
pericentromeric heterochromatin region. Meanwhile, in the subtelomeric region, Abo1 
deletion results in decreased H3K9me2 and H3K9me3 marks. RT-qPCR and ChIP-
qPCR validated these observations on different heterochromatin regions. Facultative 
heterochromatin regions, known as “determinant of selective removal” (DSR) islands 
and containing meiotic genes, were also investigated. We found that abo1∆ mutant 
compared to wild type, displayed a reduced enrichment of H3K9me2 and H3K9me3 
marks in DSR islands without any effect on gene expression indicating that Abo1 is 
required for the establishment of heterochromatin and contributes to the transition of 
H3K9me2 to me3 at DSR islands. To search for the heterochromatin assembly 
mechanism involving Abo1, we analyzed published H3K9me2 ChIP-seq data from 
several different mutant strains. Interestingly, abo1 deletion shows similar H3K9me2 
regulation patter in different heterochromatin regions to the H3K9 methyltransferase 
Clr4 point mutation Clr4W31G that inhibits the transition from H3K9me2 to H3K9me3 
through disturbing the Clr4 self-recruitment by the chromodomain.   
 
ChIP-qPCR at exampled genes for each heterochromatin regions revealed that the Clr4 
occupancy decreased in abo1∆ at subtelomeric region and pericentromeric region, 
which is consistent to the reduced H3K9me3 and the silencing defect in the same loci. 
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Clr4 enrichment in DSR islands was also significantly decreased with deletion of abo1. 
These result supported the role of Abo1 to stabilize Clr4 recruitment to allow the 
H3K9me2-H3K9me3 transition at different heterochromatin regions. By examine 
histone occupancy by H3 ChIP as well as nucleosome positioning data from previous 
published paper, we did not find significant changes in subtelomeric, pericentromeric 
and DSR heterochromatin regions, suggesting that H3K9me2 and H3K9me3 changes 
in abo1∆ cells is not induced by nucleosome dynamics or occupancy defects(Gal, 
Murton et al. 2016).  
 
Based on these findings, this work has identified Abo1 as a new factor involved in the 
H3K9 methylation process in fission yeast that we summarizes in a simplified mode 
 
In the constitutive pericentromeric region or cen-like region, silencing machinery is 
divided into two steps: 1) RNAi co-transcriptional gene silencing (RNAi-CTGS) 
followed by transcriptional gene silencing (RNAi-TGS). siRNA from the RNAi-CTGS 
activate RITE complex and help to recruit Clr4 to establish H3K9me2. In this step, 
H3K9me2 and H3ac present at the same time and still allow the transcription of dg-dh 
repeats. 2) In the RNAi-TGS step, H3K9 is tri-methylated. Swi6 is recruited to the 
H3K9me3 to establish the real transcriptional silencing (Jih, Iglesias et al. 2017). 
Deacetylase Clr3 may also involve in this process. In the facultative heterochromatin 
region, without RNAi-CTGS, Abo1 may help to recruit Clr4 promoting both H3K9me2 
and H3K9me3, leading to TGS 
 
In this study, we uncovers a role for Abo1 in stabilizing directly or indirectly Clr4 
recruitment to allow the H3K9me2 to H3K9me3 transition in heterochromatin in S. 
pombe. However, many questions about Abo1 in S.pombe still need to be answered in 
the future study. The recruitment of Abo1 to heterochromatin and Clr4 and the 
functional role of its non-canonical bromodomain are still unclear. The ATPase domain 
in Abo1 indicates its capacity of ATP hydrolysis. The functional role of ATPase domain 
in heterochromatin assembly, even in regulating genome-wide histone occupancy as a 
histone chaperone, are still not clear. Its human homolog ATAD2 has been found to 
overexpress in several types of cancer and regulates transcription of several key factors 
including Myc, and EZH2, as well as crosstalk with P53/P21 pathways (Altintas, 
Shukla et al. 2012, Lu, Chua et al. 2015, Morozumi, Boussouar et al. 2016). Since the 
exact function of the human Abo1 homolog ATAD2 in both cancer and normal cells 
remains unclear, this work open new understanding of the role of the conserved 
bromodomain AAA-ATPase heterochromatin assembly 
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4.2 Study II: The role of non-catalytic domains of Hrp3 in chromatin remodeling 
 
Chromatin is the fundamental molecular structure for packing DNA in chromosomes. 
The basic unit forming chromatin structure is a nucleosome that is consisted of ~147bp 
linear DNA wrapped around a histone octamer. ATPase dependent chromatin 
remodelers regulate chromatin structure through nucleosome sliding, nucleosome 
assembly, nucleosome unwrapping, histone eviction, and histone variants exchange 
(Cooper 2000). CHD1 is a conserved ATP dependent chromatin remodeling enzyme 
regulating H3.3 turnover and maintaining an open chromatin state in the active gene 
(Siggens, Cordeddu et al. 2015). A study in CHD1 in S.cerevisae revealed a small 
region between the ATPase catalytic domain and DNA binding domain, coupling the 
processes of nucleosome assembly and nucleosome spacing (Torigoe, Patel et al. 2013). 
SWI/SNF remodelers share a feature of specific taking nucleosome as substrate but not 
DNA. Hrp3, as one of the two the homologs of CHD1/2 remodeler in S.pombe, has 
been previously reported to act more significate role in maintaining nucleosome 
occupancy (Pointner, Persson et al. 2012). In this study, we aim to explore the functional 
roles in chromatin remodeling for the non-catalytic domains of CHD1/2 remodeler 
homolog Hrp3 in S.pombe. 
 
In this study, we generated a series of mutant strains lacking different non-catalytic 
domain of Hrp3 that is TAP tagged at its C-terminus. Affinity purification of wild type 
and mutant Hrp3_TAP was performed and found that loss of non-catalytic domains 
significantly affect the co-purification of histones. To perform in vitro studies, we 
expressed four canonical S. pombe histone proteins H3, H4 H2A, and H2B from 
optimally plasmids and E.coli strains. Overexpression of proteins in E.coli cells formed 
inclusion bodies. We extracted inclusion bodies and purified histone proteins from the 
extracts through high-performance liquid chromatography. The almost equal ratios of 
histone proteins were mixed and dialyzed to refold histone octamer. The dialyzed 
histone mix was applied to gel filtration colomun to purify the histone octamer complex. 
210 bp DNA containing ‘601’ nucleosome positioning sequence along with 70 bp of 
extra-nucleosomal DNA was amplified. It further constituted with histone octamer into 
a sp70N0 nucleosome. With affinity purification, we determined the compromised 
histone association of mutant Hrp3 in vivo compared to wild type Hrp3, through anti-
H3 western blot. With this observation, in vitro assay was applied to analyze the ATP 
hydrolyzing capacity of mutant Hrp3 compared to wild type. Using DNA and sp70N0 
nucleosome as substrate, we aimed to identify the domains that effect on catalytic 
activity. Most of the mutant Hrp3 exhibited different degrees of compromised ATPase 
activity. SANT and SLIDE sub-domains are composed of DNA binding domain in Hrp3. 
They may exert distinct functional roles, proposed from their distinct effects from 
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domain deletions on in vivo nucleosome association and ATP hydrolysis capacity. We 
also observed that Hrp3 with SANT domain and coupling region deletions exhibited 
the similar ATPase activity level by using DNA and nucleosome as substrate. It 
indicated that Hrp3 enzyme loose the preference of taking nucleosome without SANT 
domain and the coupling region. Taken together, all our data revealed that the non-
catalytic domain of Hrp3 can affect the enzymatic activity and could further affect the 
chromatin remodeling process. However, future experiments, such as the in vitro 
nucleosome binding assay, nucleosome sliding assay, still need to be done to figure out 
how these non-catalytic domain effect in remodeling process.  
 
In this study, we have down lots of works to generate the in vitro assays and established 
a platform for further exploration. 
 
 
4.3 Study III: Investigation of protein coding sequence exclusion by alternative 
transcription start site usage across the human body 
In mammalian cells, multiple protein isoforms or protein variants are transcribed from 
the same gene. This is a widespread phenomenon. Protein isoforms are produced by 
several different mechanisms, including alternative transcription initiation, alternative 
translational initiation, alternative splicing, and alternative poly A-tail. Multi-
mechanisms can also co-functionalize to produce various protein isoforms. In this study, 
we used CAGE data from the FANTOM 5 project to analyze 890 CAGE libraries in 
176 different primary cell types, aiming to explore the distribution of alternative TSSs. 
Furthermore we investigated whether their usage causes exclusion of coding sequences, 
and consequently potentially functional consequences in regulating biological 
processes. 
 
Firstly, we merged the detected TSSs located around the same loci of the same strand 
as Tag cluster (TC) to categorize detected tag clusters (TC) and their expression. All 
TCs with an expression range of at least 1 or 10 tags per million (TPM) in any of CAGE 
library were hierarchical classified. Analysis of. TCs were defined into subtypes, 
including final regions from 5’UTR, 500bp upstream region of TSS to 3’UTR. In one 
primary cell as an example, most TCs could be mapped to RefSeq genes. Within this 
group, most TCs could be mapped to the same strand of genes, of which most (over 
70%) were characterized as unknown novel TSS. Within TC group of unknown TSSs, 
most TCs (96%) could be mapped to the coding genes but not to the annotated TSS of 
the gene, which may induce potentially exclusively protein-coding. Combining the 
hierarchical classification in all CAGE-libraries, we further identified that annotated 
TSSs of protein-coding gene and ncRNA are ubiquitously expressed, while the 
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expression of TSS located in intergenic regions, antisense strand and within coding 
region turns out more cell-specific.   
     
We then re-examined this hierarchical classification analysis of all TCs expressed in 
each CAGE-library and clustered the analysis for each specific primary cell type, 
aiming to identify whether the distribution patterns across the classification tree were 
different between cell types. Surprisingly, the analysis revealed a stable fraction of each 
TCs category throughout cell types. Hematopoietic cells, especially monocytes with 
different inductions were outliers with less annotated TSS usage of transcript genes and 
more intragenic TSS usage. Then we narrowed down the analysis in hematopoietic cells 
with percentages of usage of various types of TCs. The hematopoietic cells include 
progenitors, myeloid and lymphoid cells. Interestingly, TCs in annotated TSS of 
protein-coding gene and TCs within 5’UTR were more preferred in hematopoietic 
progenitor cells, while TCs within the protein-coding region was more favored in 
matured myeloid cells. Lymphoid cells exhibited preference of TCs between 
progenitors and myeloid cells. 
 
TCs within the protein-coding region represents the TSSs that potentially generate 
coding sequences truncated protein and may change the functions of the expressed 
protein. In our analysis, 7.8% of total TCs mapped to the Refseq protein-coding 
transcripts belong to this kind of TSS. Over half of the genes have this kind of TSS that 
has been previously annotated and further supported by CAGE data in our study. We 
also analyzed the expression pattern (with a cutoff 10TPM) of these TCs potentially 
leading truncated proteins. The TCs mapped to annotated TSS leading truncated protein 
were more cell-specific compared to the TCs mapped to annotated TSS leading to no 
truncations. However, no significant functional clustering of genes mapped by the TCs 
of coding sequence exclusion was found. However, considering cell type, we observed 
a subgroup of immune cells, including blood cells. 
 
In the next step, we aimed to define the main and alternative TSSs. Usually, the most 
upstream TSS is commonly viewed as the main TSS. Nevertheless, this definition is 
not based on expression level. Only 33% of genes exhibited the most upstream TSS, 
and most expression at the same time. Over half of the genes, harboring annotated or 
all coding sequence exclusive TSS, showed the higher expression of coding sequence 
exclusive TSS than other TSSs. Our analysis suggested that the most upstream TSSs of 
coding genes are not always the most expressed TSSs, but are more universal used in 
different cell types. Therefore, we still kept the common view of main and alternative 
TSS in the following analysis.   
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Furthermore, we set out filters of TCs to explore the cell-specific expression of 
alternative TSS leading protein domain loss. Within TCs mapped to annotated coding 
TSS, 78 protein domains from 36 genes could be excluded in a cell-specific manner. 
Within all TCs, this number of genes increased to 286, with 715 protein domains. In 
hematopoietic cells, we identified a total of 60 genes that have potential alternative TSS 
leading to domain exclusion according to specific cell type or specific differentiation 
lineage. This observation was further validated by RT-qPCR of examples PRDM1, 
KDM2B, RERE in different sorted hematopoietic cells, suggesting the different usage 
of alternative TSS of genes may result in distinct functional consequences in 
hematopoiesis. 
 
To explore the functional changes caused by alternative TSS usage in different 
hematopoietic cells, we took the H3K4 and H3K36 demethylase KDM2B as an 
example for further studies. KDM2B can regulate lineage commitment in normal and 
malignant hematopoiesis in mice (Andricovich, Kai et al. 2016). Studies in mice also 
showed the presence of two isoform proteins of KDM2B: the full-length one and the 
short one that lacks JmjC catalytic domain (He, Shen et al. 2013). The CAGE analysis 
revealed three TSS in KDM2B. The most expressed TSS1 and TSS3 matched the 
reported isoforms in mice. They showed different expression levels in lymphoid and 
myeloid cells. We speculated that the short isoform might participate more specifically 
in the PRC1.1 complex to locate unmethylated CpG islands. To investigate consequent 
functional changes with the usage of alternative TSS of KDM2B, we knocked down 
the TSS1 and alternative TSS3 in Jurkat cells and performed analysis on RNA-seq and 
the PRC1.1 target H2AK119ub, with ChIP-seq. Our analysis showed the differences 
between knocking down these two TSS. The more significant changed in both RNA-
seq and ChIP-seq were present in TSS1 knockdown cells, while no significant changes 
were observed for knocking down both TSS1 and TSS3 compared to the control, which 
contradict our hypothesizes. 
 
We performed CAGE analysis with 16 human time course to identify protein domain 
loss during differentiation. A total 76 genes were identified harboring different TSS 
usage to express different isoforms, which some of them were unknown before. 
 
In this study, we characterized alternative TSS usage of genes, especially in 
hematopoietic cells. We further explored how the isoform regulation is associated with 
differentiation or cell type. We discovered two kinds of domain loss according to usage 
of TSS within coding region: varying numbers repeated domains such as NFLX1, or 
functional domain loss such as MYO10. The whole analysis and methods were based 
on RNA level. We still lack the evidence of whether these unannotated alternative TSS 
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usage leading to potential domain exclusion can be transcribed into real proteins. We 
could not confirm our functional hypothesis of KDM2B alternative TSS expression due 
to technical problems.     
 
 
4.4 Study IV: A regulatory role for CHD2 in myelopoiesis 
 
Epigenetic regulators play a crucial role in regulating hematopoiesis via different 
biological processes as cell proliferation, differentiation, and self-renewal. In this study, 
we aimed to study the role of chromatin factors in hematopoietic development. Stable 
K-562-Cas9 cells were generated and transduced with a unique CRISPR guide library 
that targets 1092 epigenetic regulators and 320 control genes with four sgRNAs for 
each. The transduced cells were 72 hours treated by phorbol 12-myristate 13-acetate 
PMA for megakaryocytic differentiation, or DMSO for control.  
 
After the PMA treatment, megakaryocyte differentiation was observed by morphology 
changes. Furthermore, treated cells were grouped and examined through the expression 
of surface marker for megakaryocyte differentiation (CD41 and CD61) with flow 
cytometry. With the set gating, we collected undifferentiated population harboring both 
negative CD61-/CD41- (P1), differentiated population harboring both positive 
CD61+/CD41+ (P2), and differentiated population only positive for CD61+ (P3). For 
each population, cells are sequenced to identify the guide sequences in each population. 
The top 10% overlapped genes for two biological-replicates for enriched sgRNA, 
and >0.2 mean log fold change (average of all four guides) were chosen for further 
analysis. In P1, 14 candidate genes were suggested a role of driving the myeloid 
differentiation. In P2 and P3, 13 and 30 candidate genes were suggested to inhibit the 
differentiation, respectively. Several members of the CHD chromatin remodeler family 
have been found to be involved in pluripotency and myeloid leukemia (Gaspar-Maia, 
Alajem et al. 2009, Heshmati, Türköz et al. 2018). Therefore, CHD2 from the P3 group 
was selected for further validation and characterization. 
 
To validate the observation of CHD2 from CRISPR screening, we used CRISPR-Cpf1 
to knockout CHD2 in K-562 cells with four sgRNA located in exons 3, 7, 14, and 28 of 
CHD2. Empty Py095 vector was transduced as control. Cells were sorted and collected 
by GFP expression. The single sorted cells were expanded as mono clones. We 
confirmed the CHD2 KO via western blot and Sanger sequencing of the sgRNA sites 
for indel formation. Instead of 72 hours, 24 hours of PMA/DMSO treatments were 
applied to mono clones to observe the early effect of differentiation. Significantly 
increased enrichment in the P2 population for DMSO control was observed without 
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PMA induction, suggesting spontaneous differentiation in CHD2 KO cells. PMA 
induction further enhanced the differentiation, suggested a consistent role of CHD2 in 
inhibiting myeloid differentiation. To identify if the effect for CHD2 KO in 
differentiation was coupled with cell proliferation, proliferation analysis of both control 
cells and CHD2 KO cells was performed for four days. The results showed that CHD2 
KO cells had a low proliferation rate at low cell density. In addition, colony-forming 
assay showed a reduced colony-forming capacity of CHD2 KO cells. CHD2 has been 
shown to be recruited at the TSS region by RNA PolII, and to regulate nucleosome 
disassembly (Siggens, Cordeddu et al. 2015). Through analyzing CHD2 enriched genes 
in K-562 cells from ENCODE project and overall transcriptome in K-562 cells from 
FANTOM 5 CAGE data, we revealed that CHD2 target genes participated in multiple 
cellular processes and were highly transcribed. This suggests that CHD2 is associated 
with active transcription. This conclusion was subsequentially validated by RNA-seq 
in CHD2 KO clones, where CHD2 target genes were significantly down-regulated in 
comparison with CHD2 non-target genes. We also found that the CHD2 co-expressed 
genes in AML patients overlapped with CHD2 target genes in K-562 cells. Together, 
the results suggested that CHD2 also positively regulates transcription in AML patients.   
   
In conclusion, we utilized a CRISPR-cas9 screen as an efficient method to study 
the role of epigenetic regulators (1092 factors in the library for this study) in 
hematopoiesis. Of those factors 5% exhibited potential regulation in megakaryocyte 
differentiation. CHD2, a chromatin remodeler, has been reported to regulate muscle 
differentiation. This regulation may depend on its promotion of H3.3 deposition at 
myogenic loci together with interaction with MyoD (Harada, Okada et al. 2012). 
Previous study in our group revealed that CHD2 is involved H3.3 deposition in myeloid 
cells (Siggens, Cordeddu et al. 2015). CHD2 has been shown to be ubiquitously 
expressed in hematopoiesis (Prasad, Rönnerblad et al. 2014). Thus, suggesting a general 
regulation of CHD2 in all hematopoietic cells. Our finding of CHD2 for prohibition of 
differentiation and promotion of cell growth confirms its importance of CHD2 in 
myeloid hematopoiesis, especially megakaryocytic differentiation. 
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